WASHINGTON, D.C. — US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
The funding will help Moderna "enhance mRNA platform capabilities so that the US is better prepared to respond to other emerging infectious diseases," the Department of Health and Human Services (HHS) said in a statement.
